rfhg_205015.1

Basic information about the TSS

---

TSS ID: rfhg_205015.1 Species: human Chr: chr19		Start: 804570 End: 804592 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000585956.5:31 GeneID: 5725 HGNC/MGI_ID: HGNC:9583 UniProt_ID: K7EK45 Nearer transcript ids and distances: LF330724:-136 MA566301:-136 ENST00000621737.4:-181 ENST00000587136.1:266 NR_039900.2:348 LG052883:348 LY497759:348 LY498822:348 LY499259:348 LY500574:348 LZ238806:348 MS869493:348 MS880574:348 MS996825:348 MA822766:348 LY616570:348 MB407900:348 MC002669:348 LY497940:349 LY497941:349 LY498841:349 LY498842:349 LY499547:349 LY499548:349 LY500762:349 LY500763:349 LZ239094:349 LZ239095:349 MS869681:349 MS869682:349 MS880862:349 MS880863:349 MS997006:349 MS997007:349 FR773039:349 LF137547:349 LF160757:349 LF162512:349 LF953264:349 LG005609:349 LG053305:349 LG240544:349 LP951884:349 LQ072167:349 LQ724689:349 LV470629:349 LY497582:349 LY498806:349 LY498981:349 LY500388:349 LZ238546:349 MA406097:349 MA645668:349 MA733552:349 MS869307:349 MS880296:349 MS996648:349 MA802721:349 MA823108:349 MA822429:349 MP129319:349 MP162242:349 MP168085:349 LY616858:349 LY616859:349 LY616310:349 MB407933:349 MB407857:349 MB481512:349 MC002644:349 FR773038:385 LF160811:385 LQ072166:385 MA405828:385 MA645667:385 MA733551:385 MA802720:385 view more...

Gene_name: polypyrimidine tract binding protein 1 Gene_symbol: PTBP1 Gene_synonyms: HNRNP-I HNRPI PTB-1 PTB2 PTB3 PTB4 pPTB Gene_source: HGNC:9583

TATA-Box annotation

---

Distance to TSS:	-359
Nearest PromoterID:	NR_039900
Entrez ID:	100616459
Nearest Unigene:
Nearest Refseq:	NR_039900
Nearest Ensembl:	ENSG00000284361
Gene Name:	polypyrimidine tract binding protein 1
Gene Alias:	mir-4745
Gene Type:	ncRNA
CpG%:	0.045455
GC%:	0.695652
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PTBP1 p2@PTBP1 p3@PTBP1 p4@PTBP1 p5@PTBP1
Sample		p1@PTBP1	p2@PTBP1	p3@PTBP1	p4@PTBP1	p5@PTBP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	373.83	125.65	7.79	3.51	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	392.09	134.95	6.47	3.84	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	421.50	136.96	6.94	3.47	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	364.05	119.34	4.57	4.99	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	383.79	110.68	5.40	4.50	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	400.99	119.58	3.88	3.68	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	407.22	139.01	4.14	3.92	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	362.12	136.37	8.48	1.21	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	338.10	154.09	3.85	3.42	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	264.31	203.45	4.06	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	268.01	174.63	4.04	3.64	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	271.98	182.54	2.44	4.07	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	55.13	42.39	0.81	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	54.88	36.99	0.60	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	52.03	37.32	0.44	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	52.56	36.97	1.01	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	57.22	34.51	0.87	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	54.84	36.28	0.42	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	57.58	35.19	1.07	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	52.05	33.55	0.60	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	56.94	31.27	1.07	1.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	68.36	39.88	0.86	1.38	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	60.10	39.16	0.65	1.16	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	69.16	30.33	0.00	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	71.21	34.05	0.52	1.29	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	72.48	41.15	0.95	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	89.01	39.56	0.55	4.95	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	103.26	36.07	0.94	1.41	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	65.58	28.91	0.48	1.13	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	72.21	30.58	0.36	1.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	68.87	29.10	0.84	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	79.52	28.72	0.78	1.37	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	67.11	33.34	0.84	2.53	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	104.41	36.29	0.99	0.49	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	69.37	32.54	1.31	0.75	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	70.71	33.92	0.77	0.77	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	78.07	31.47	0.00	1.43	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	87.04	38.28	1.21	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	83.73	36.73	0.27	0.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	74.18	37.69	0.96	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	78.58	32.00	0.47	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	83.74	37.18	0.59	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	74.66	33.74	0.84	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	74.83	40.04	0.70	1.05	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	78.30	37.95	1.00	0.80	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	76.08	34.66	0.70	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	75.33	30.23	1.68	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	74.51	28.91	0.30	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	85.46	34.47	1.20	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	75.42	28.91	0.20	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	76.86	30.95	0.82	1.23	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	90.06	36.91	1.56	1.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	83.39	34.78	2.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	82.51	38.44	0.99	1.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	139.26	20.13	0.84	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	118.94	32.15	2.30	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	82.32	36.62	1.62	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	64.88	35.33	0.96	1.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	113.47	28.60	0.00	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	88.13	38.07	1.41	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	62.81	42.62	1.68	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	81.21	15.13	1.59	3.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	85.28	26.16	0.34	1.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	52.64	31.84	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	56.44	29.82	0.00	2.13	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	23.69	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	61.43	37.54	1.46	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	57.52	44.63	3.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	61.45	34.25	1.88	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	40.41	35.44	1.99	1.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	37.12	39.60	0.93	0.93	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	42.50	36.38	0.31	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	83.31	29.78	0.32	0.32	0.63
Adipocyte - breast, donor2	11327-117E4	72.03	29.68	2.25	0.16	0.80
Adipocyte - omental, donor1	11473-119C6	66.67	31.04	0.13	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	42.61	32.89	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	56.94	18.09	0.00	0.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	42.11	25.52	0.64	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	27.49	14.29	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	66.39	40.65	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	42.23	32.84	0.70	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	69.23	62.39	0.20	0.20	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	50.96	29.86	0.77	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	30.66	23.97	0.00	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	48.20	41.73	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	53.65	38.77	0.32	0.16	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	49.70	21.30	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	41.59	26.13	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	35.06	30.05	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	31.61	23.71	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	44.21	25.37	0.25	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	35.34	24.54	0.00	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	25.58	14.61	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	267.41	123.98	0.66	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	346.75	109.01	3.94	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	83.86	45.52	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	183.68	98.41	1.08	0.18	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	120.49	63.59	0.00	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	133.54	58.35	0.41	0.00	0.41
Anulus Pulposus Cell, donor1	11248-116E6	55.04	54.81	0.34	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	46.53	33.55	0.24	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	57.51	35.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	75.54	39.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	53.51	19.26	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	66.66	35.57	0.90	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	53.12	29.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	41.58	24.42	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	66.28	26.64	0.32	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	64.56	38.35	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	39.20	21.38	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	61.77	34.65	2.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	66.04	31.20	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	35.11	20.06	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	46.46	32.12	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	49.13	25.93	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.59	25.18	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	67.51	40.72	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	52.34	29.47	0.57	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	52.92	32.61	0.27	0.53	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	46.82	36.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	52.91	31.18	0.83	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	42.03	27.62	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	28.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	63.47	38.25	0.34	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	29.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	70.87	34.47	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	65.65	32.63	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	33.92	25.44	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	53.58	33.63	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	47.67	30.36	0.64	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	35.10	19.61	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	58.18	34.25	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	55.31	28.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	47.09	25.68	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	60.83	33.93	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	50.58	33.72	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	42.77	32.08	1.19	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	61.03	34.58	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	53.23	27.25	2.04	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	43.21	23.51	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	59.98	41.86	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	51.02	26.67	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	37.70	20.88	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	57.63	41.57	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	53.40	29.84	0.00	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	39.38	37.06	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	80.28	48.59	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	55.10	33.02	0.43	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	51.14	23.46	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	70.71	34.26	1.46	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	58.39	32.18	0.92	0.23	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	51.01	22.95	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	30.00	22.37	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	73.08	40.46	0.83	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	49.27	27.23	0.31	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	72.66	36.81	0.48	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	59.20	33.48	1.55	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	65.61	27.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	60.93	24.37	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	59.58	38.40	0.53	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	48.34	22.90	1.09	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	293.78	164.08	1.11	0.25	0.37
Astrocyte - cerebellum, donor2	11580-120F5	199.40	107.49	1.71	0.17	0.68
Astrocyte - cerebellum, donor3	11661-122F5	117.25	72.99	1.05	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	129.33	89.24	0.70	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	169.54	102.08	2.91	0.97	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	180.63	89.50	1.79	1.04	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	219.85	170.54	4.13	1.38	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	264.09	172.51	2.13	1.75	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	224.07	157.84	1.37	1.71	0.23
Basophils, donor1	12241-129G9	71.14	59.11	0.00	0.26	0.00
Basophils, donor2	12242-129H1	80.10	59.53	0.00	1.08	0.00
Basophils, donor3	12243-129H2	85.41	94.08	0.15	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	124.62	72.44	0.86	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	192.93	87.32	2.29	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	93.26	57.39	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	143.73	42.05	1.26	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	203.38	58.02	1.46	0.00	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	105.47	67.48	0.92	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	79.54	52.54	1.80	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	203.02	124.80	0.93	0.82	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	148.36	115.75	0.70	1.63	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	160.85	83.46	0.32	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	41.37	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	66.50	65.37	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	60.13	60.69	0.19	1.11	0.19
CD14+ Monocytes, donor3	11381-118B4	57.08	48.30	0.88	1.32	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	74.16	31.70	0.00	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	48.52	32.60	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	61.47	33.20	0.33	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	92.95	59.99	1.30	1.01	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	72.42	37.72	0.60	1.21	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	67.04	54.96	0.71	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	75.16	54.74	0.50	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	72.04	40.30	0.55	1.10	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	95.20	45.37	0.25	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	61.48	44.64	0.59	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	48.79	32.05	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	63.55	40.26	0.44	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	63.45	45.89	0.70	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	91.88	50.16	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	104.28	37.72	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	72.44	51.47	0.89	0.45	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	81.02	40.71	0.60	1.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	60.59	34.98	0.42	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	79.39	45.99	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	56.10	34.16	0.23	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	75.51	40.59	0.44	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	63.75	44.65	0.81	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	68.04	46.93	0.17	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	80.80	59.76	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	56.03	40.97	0.18	1.10	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	54.95	28.18	0.70	1.06	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	80.29	27.64	1.32	0.00	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	62.08	42.02	0.70	1.57	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	52.41	40.51	0.74	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	71.35	49.15	0.22	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	48.73	45.45	1.23	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	48.91	32.68	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	56.84	33.41	0.23	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	66.48	46.21	0.44	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	74.61	60.06	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	49.39	52.20	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	81.60	84.71	0.47	0.31	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	74.22	75.62	0.70	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	72.24	72.69	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	62.01	37.77	0.26	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	75.97	55.99	0.44	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	57.06	47.37	0.00	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	77.23	48.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	88.14	50.85	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	85.95	55.92	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	75.69	52.24	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	127.58	76.12	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	102.48	59.66	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	90.20	51.77	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	94.92	61.96	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	113.42	106.85	0.00	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	91.40	83.42	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	115.61	109.55	0.00	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	266.68	120.41	0.81	2.02	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	165.39	90.68	1.20	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	56.23	44.18	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	66.86	55.62	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	189.38	83.42	0.75	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	206.54	74.41	0.00	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	97.12	90.69	0.00	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	87.57	88.79	0.61	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	121.08	90.58	1.22	2.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	68.66	72.74	0.26	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	79.06	87.37	0.22	1.35	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	56.63	75.31	0.00	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	139.38	92.92	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	124.31	96.92	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	105.48	118.66	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	72.84	72.98	0.14	0.29	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	86.93	77.27	0.68	2.03	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	74.96	69.32	0.64	1.61	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	99.07	81.14	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	92.59	77.91	0.35	0.35	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	93.28	79.20	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	80.96	90.23	0.84	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	87.89	76.87	1.04	1.87	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	77.18	69.50	0.67	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	134.34	109.59	0.54	1.09	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	140.95	119.52	0.00	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	109.39	111.18	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	113.30	87.52	0.74	0.56	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	103.98	87.30	0.43	1.30	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	94.78	98.56	0.42	0.63	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	90.00	73.82	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	104.41	82.32	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	124.64	91.09	0.00	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	125.70	88.09	0.99	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	101.55	61.85	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	101.90	75.37	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	123.23	104.96	0.55	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	130.06	109.44	0.00	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	101.64	86.24	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	127.13	85.59	0.00	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	121.88	72.02	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	120.81	79.23	0.00	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	85.97	62.70	0.38	2.25	0.00
CD8+ T Cells, donor3	11383-118B6	125.49	80.54	0.76	3.79	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	219.99	59.18	2.52	2.75	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	208.97	57.27	2.16	2.64	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	190.42	49.79	2.46	1.92	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	335.64	78.66	4.50	1.80	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	213.82	71.51	2.64	2.64	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	221.25	55.94	3.18	1.59	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	263.13	62.36	3.26	1.74	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	275.84	53.69	2.63	1.32	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	268.52	54.64	2.11	1.88	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	276.52	60.68	3.32	4.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	235.31	43.58	2.61	3.78	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	215.55	68.74	2.93	1.07	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	149.71	52.09	1.31	3.06	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	171.24	54.65	1.82	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	131.27	35.80	0.75	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	231.94	73.47	3.24	2.52	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	225.86	61.57	3.74	2.30	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	193.51	56.57	1.89	1.18	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	274.76	70.35	4.12	1.58	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	233.75	69.82	2.46	1.54	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	246.85	64.44	1.60	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	216.86	53.55	1.53	1.91	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	215.58	57.54	4.73	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	195.15	57.49	3.03	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	154.17	42.56	2.41	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	144.78	49.66	1.40	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	146.26	62.11	0.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	56.66	16.45	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	101.29	49.41	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	94.18	48.83	0.32	0.00	0.21
Chondrocyte - de diff, donor1	11261-116G1	113.01	58.93	0.69	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	63.61	34.83	0.00	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	79.65	30.83	1.02	0.46	0.23
Chondrocyte - re diff, donor2	11339-117F7	73.41	60.88	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	50.55	36.80	0.81	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	142.07	77.92	1.38	0.23	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	115.65	50.88	1.07	1.28	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	143.99	54.87	1.24	0.53	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	106.46	62.17	0.28	0.28	0.28
Corneal Epithelial Cells, donor1	11526-119I5	182.46	95.51	0.88	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	188.84	62.57	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	171.02	58.80	1.28	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	71.49	11.72	0.66	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	76.01	11.04	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	10.35	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	86.18	12.74	0.43	0.00	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	100.78	103.52	0.34	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	97.28	82.91	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	75.50	80.33	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	182.28	59.20	0.50	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	99.75	42.83	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	196.83	60.24	0.85	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	77.06	23.98	0.79	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	155.91	57.01	0.87	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	310.33	80.23	2.59	0.47	0.94
Endothelial Cells - Artery, donor3	11413-118E9	236.67	71.70	0.88	0.00	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	97.75	43.00	0.66	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	91.58	30.73	1.22	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	141.23	40.59	0.56	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	182.74	65.37	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	105.17	50.50	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	96.56	35.59	1.13	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	263.68	108.03	1.60	1.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	161.95	41.93	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	281.29	90.95	1.99	0.25	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	146.65	42.37	1.52	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	199.43	60.33	0.73	0.24	0.37
Endothelial Cells - Vein, donor1	11267-116G7	161.53	61.43	3.41	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	182.31	92.20	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	164.70	58.09	0.94	0.16	0.31
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	84.16	46.21	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	28.53	21.40	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	162.72	78.67	1.71	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	126.89	62.40	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	146.42	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	62.40	30.38	0.82	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	34.38	12.59	1.09	0.00	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	62.19	29.79	1.95	0.00	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	97.39	48.27	1.09	0.12	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	79.02	43.40	0.41	0.82	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	60.01	34.80	1.05	0.11	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	91.17	66.40	0.79	1.05	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	110.29	56.14	1.00	0.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	103.43	48.54	1.36	0.00	1.36
Fibroblast - Cardiac, donor2	11345-117G4	114.45	78.83	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	88.16	42.43	1.26	0.16	0.47
Fibroblast - Cardiac, donor4	11452-119A3	83.96	50.32	0.61	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	86.17	50.76	1.02	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	149.32	54.27	1.67	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	154.89	57.88	0.67	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	74.21	28.47	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	115.72	124.51	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	125.01	214.96	0.92	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	72.59	57.16	0.51	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	54.94	46.72	0.47	0.23	0.94
Fibroblast - Dermal, donor2	11346-117G5	146.69	79.24	1.42	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	68.42	51.62	0.85	0.48	0.60
Fibroblast - Dermal, donor4	11450-119A1	111.35	85.58	1.13	0.23	0.34
Fibroblast - Dermal, donor5	11454-119A5	174.28	100.14	1.22	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	206.12	106.71	2.44	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	72.46	57.26	0.21	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	85.41	43.49	0.52	0.26	1.83
Fibroblast - Gingival, donor2	11318-117D4	132.31	89.48	1.98	0.92	0.00
Fibroblast - Gingival, donor3	11394-118C8	76.58	56.08	0.68	0.10	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	55.06	50.91	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	57.09	28.54	0.53	0.00	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	173.04	72.80	0.94	0.31	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	120.76	59.64	0.27	0.27	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	104.45	38.46	0.00	0.00	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	84.68	41.68	0.88	0.15	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	109.22	47.72	0.55	0.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	132.73	58.14	1.32	0.33	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	51.80	27.15	0.00	0.59	0.88
Fibroblast - Lung, donor1	11270-116H1	82.92	76.12	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	73.12	92.51	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	121.98	109.95	2.11	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	308.22	212.42	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	90.91	74.13	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	93.48	66.89	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	259.82	183.09	1.62	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	175.75	115.83	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	101.26	23.83	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	134.04	97.76	0.39	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	189.15	116.19	1.06	0.61	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	119.64	86.29	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	96.55	49.61	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	85.86	36.72	0.27	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	52.42	28.41	0.35	0.00	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	139.27	45.87	0.66	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	242.41	147.72	0.81	0.00	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	175.07	106.91	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	67.21	54.16	1.19	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	203.41	108.15	0.60	3.18	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	67.49	41.03	0.36	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	75.09	47.10	0.00	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	176.30	88.75	0.30	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	116.59	54.19	0.22	0.11	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	138.68	82.00	0.76	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	85.32	38.39	0.16	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	145.77	96.64	0.40	1.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	87.30	49.33	0.40	0.10	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	198.87	109.11	0.91	0.91	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	66.03	37.94	0.33	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	81.54	38.46	1.03	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	117.25	67.33	0.66	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	99.49	54.86	0.64	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	139.50	72.36	0.67	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	85.94	21.01	1.25	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	66.48	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	50.55	41.83	0.87	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	110.08	36.06	0.00	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	124.92	48.67	0.26	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	131.08	37.56	0.26	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	240.38	115.60	0.77	2.30	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	312.02	112.94	2.55	2.55	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	239.91	112.39	2.85	4.85	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	105.34	127.68	1.65	4.41	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	86.54	81.74	1.60	2.28	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	198.13	105.80	1.59	1.78	2.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	116.57	131.11	1.59	4.49	7.67
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	75.99	75.01	0.98	1.30	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	223.32	88.89	1.77	2.21	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	232.05	147.26	1.84	1.13	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	185.82	111.20	0.99	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	219.74	117.66	2.42	1.88	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	198.35	146.57	1.86	0.87	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	209.99	149.92	2.63	0.28	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	171.59	99.21	2.44	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	160.18	105.65	0.23	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	150.10	102.39	2.87	0.62	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	141.42	101.86	2.19	1.31	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	160.15	95.74	1.48	1.18	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	177.08	119.85	1.75	1.11	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	152.15	85.79	0.45	0.22	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	160.70	111.30	2.42	1.01	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	156.92	105.86	0.85	0.51	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	210.68	125.12	0.62	0.35	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	188.34	169.40	0.73	0.42	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	153.02	165.82	0.00	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	136.66	107.56	1.00	0.66	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	164.40	110.98	1.25	0.25	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	142.52	126.39	1.23	0.61	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	135.34	102.33	1.24	0.62	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	133.28	122.10	1.27	0.69	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	125.91	93.72	0.83	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	110.22	96.11	1.76	0.66	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	118.20	106.51	1.48	0.61	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	153.18	91.10	0.65	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	101.35	87.23	1.92	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	103.85	84.62	1.04	0.09	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	107.09	87.63	1.90	0.63	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	106.73	93.66	2.43	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	116.77	85.09	1.46	0.31	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	84.53	79.26	1.10	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	88.09	79.96	1.68	0.00	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	90.92	62.68	0.28	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	94.93	62.31	1.34	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	121.18	76.04	1.07	0.31	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	120.86	73.32	1.17	0.52	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	76.71	58.82	1.36	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	87.75	59.73	0.18	0.37	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	87.51	62.94	0.66	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	85.29	67.44	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	100.12	59.89	0.26	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	82.32	58.51	0.81	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	152.24	116.91	0.00	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	326.26	167.61	2.39	0.60	2.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	253.76	139.28	2.77	0.77	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	304.83	177.78	0.82	1.43	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	253.79	100.76	1.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	243.00	100.87	1.13	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	207.08	121.30	4.15	1.38	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	240.06	81.67	2.47	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	274.25	102.50	1.55	1.93	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	170.07	121.94	8.02	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	234.74	128.67	1.74	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	205.38	85.60	0.98	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	212.08	100.48	2.06	2.06	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	189.94	106.63	3.33	13.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	193.80	103.19	2.52	1.96	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	212.12	105.90	2.29	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	202.16	93.11	5.03	6.71	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	216.29	101.46	2.54	0.95	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	218.74	98.16	2.38	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	171.23	71.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	222.21	130.00	0.57	1.72	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	191.21	110.11	1.48	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	194.83	71.15	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	222.43	107.28	3.73	2.07	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	230.82	108.39	4.83	0.69	3.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	152.79	84.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	162.22	88.03	2.31	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	157.12	75.63	1.96	1.96	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	88.96	52.84	1.34	0.67	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	157.96	109.80	0.77	1.16	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	230.05	132.83	2.74	4.11	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	116.79	101.88	2.48	7.45	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	147.69	99.09	0.94	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	131.56	108.63	2.41	4.22	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	121.57	110.38	3.05	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	155.15	104.50	3.59	1.99	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	146.53	92.75	1.48	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	101.52	107.42	4.72	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	126.02	93.93	0.00	2.92	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	126.84	113.23	1.76	0.88	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	134.78	82.23	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	106.25	76.41	2.39	5.37	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	122.28	74.24	3.40	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	70.76	55.92	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	111.02	38.67	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	98.95	59.60	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	58.99	39.96	0.63	1.27	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	37.60	22.56	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	175.92	44.91	2.44	0.35	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	187.54	45.58	2.03	0.68	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	186.10	42.09	1.59	0.46	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	176.10	45.36	1.53	0.66	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	178.59	48.36	2.15	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	160.39	44.99	2.37	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	168.00	37.86	1.49	0.50	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	149.76	47.86	0.86	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	156.66	32.36	1.28	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	216.57	53.16	1.68	0.00	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	208.61	96.51	1.73	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	103.11	63.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	206.34	87.83	1.41	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	118.42	61.03	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	158.40	59.10	2.10	0.35	0.17
Hepatocyte, donor1	11523-119I2	66.58	21.79	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	74.34	51.71	1.08	0.00	2.15
Hepatocyte, donor3	11684-122I1	56.45	28.84	0.00	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	246.72	102.47	1.96	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	255.88	43.52	1.57	0.70	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	104.00	55.43	0.55	0.41	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	366.15	267.45	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	333.77	260.34	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	325.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	339.17	209.04	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	227.74	220.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	237.37	367.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	402.38	261.42	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	306.24	297.10	4.57	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	417.45	303.75	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	468.51	201.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	315.86	239.62	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	501.60	291.16	3.97	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	421.29	180.71	1.11	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	413.82	298.58	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	460.43	207.85	3.78	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	442.33	201.06	4.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	321.96	160.98	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	574.97	258.42	1.94	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	553.81	249.54	9.66	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	549.62	286.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	731.76	322.69	4.07	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	561.71	260.28	2.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	359.31	186.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	581.87	240.30	3.21	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	429.33	183.73	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	361.94	241.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	418.70	183.62	4.72	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	445.33	151.47	2.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	309.59	132.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	520.84	247.51	4.30	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	555.19	229.95	5.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	410.76	312.18	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	601.33	260.81	3.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	470.25	251.53	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	252.87	252.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	531.98	245.64	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	464.56	298.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	375.27	271.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	349.09	154.95	2.47	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	433.74	182.63	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	348.89	226.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	381.77	188.45	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	265.57	223.52	2.21	4.43	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	262.60	210.73	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	245.88	182.23	3.49	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	188.98	209.23	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	289.22	247.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	266.69	190.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	378.23	231.37	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	384.70	265.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	335.03	186.85	5.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	217.82	202.70	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	217.30	298.02	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	187.15	171.29	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	128.03	43.33	0.57	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	115.37	83.16	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	155.14	68.91	1.33	0.76	0.47
Keratinocyte - oral, donor1	11251-116E9	180.04	105.00	1.70	0.34	0.23
Keratocytes, donor1	11527-119I6	139.94	245.15	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	106.63	100.77	2.34	0.00	1.17
Keratocytes, donor3	11688-122I5	53.15	73.31	1.19	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	4.40	2.20	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	137.00	73.35	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	100.22	65.16	0.69	0.69	0.00
Lens Epithelial Cells, donor3	11690-122I7	87.29	46.32	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	114.90	41.38	0.83	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	99.63	36.00	0.84	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	114.60	40.77	1.10	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	83.35	32.26	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	98.65	37.50	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	103.50	31.91	1.08	0.11	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	96.03	36.94	0.82	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	112.76	40.70	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	102.61	35.05	1.41	0.42	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	79.11	37.97	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	103.34	45.37	0.39	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	96.46	33.14	0.74	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	89.54	35.89	0.70	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	116.64	49.14	0.95	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	106.58	36.67	0.82	0.41	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	91.46	43.42	0.92	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	111.92	41.46	0.62	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	128.46	43.73	0.91	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	86.56	38.51	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	115.39	38.95	1.46	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	122.47	42.57	1.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	100.87	41.22	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	107.18	45.24	0.27	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	110.81	39.21	0.30	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	75.17	42.51	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	106.79	47.32	0.63	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	110.07	40.75	1.35	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	86.67	36.46	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	96.52	41.96	1.13	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	106.14	39.97	1.91	0.21	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	81.41	35.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	77.74	44.33	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	119.56	37.17	1.36	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	106.25	39.61	1.11	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	92.90	38.79	0.74	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	98.58	40.56	0.82	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	86.84	39.88	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	92.21	46.56	0.00	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	104.97	37.09	1.12	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	77.51	36.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	98.89	57.69	1.94	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	106.59	41.24	1.40	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	102.06	40.11	0.00	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	109.76	48.35	1.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	113.00	40.49	0.94	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	128.70	51.60	0.25	0.25	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	104.50	55.58	0.51	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	108.60	39.68	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	167.68	45.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	220.93	32.99	2.30	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	219.70	32.66	2.23	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	209.87	38.50	2.12	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	224.36	33.76	2.11	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	178.39	34.56	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	192.20	26.28	3.61	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	186.75	38.06	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	199.50	26.92	0.68	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	157.34	21.52	3.20	0.58	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	180.07	32.86	0.45	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	266.64	40.51	1.22	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	183.84	35.95	1.03	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	192.66	31.40	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	185.23	35.98	1.33	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	205.79	32.09	3.57	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	198.77	33.35	2.40	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	214.83	37.03	1.89	0.76	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	204.32	31.29	3.68	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	245.44	31.80	2.45	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	197.21	35.40	1.67	1.04	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	197.58	30.27	1.96	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	252.43	31.94	5.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	216.28	34.55	3.19	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	190.12	29.00	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	188.66	38.73	1.11	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	241.79	41.36	2.12	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	204.67	29.50	1.84	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	194.57	26.48	4.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	225.65	41.45	6.14	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	220.22	27.74	2.26	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	254.35	32.00	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	205.61	43.83	3.62	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	206.83	30.16	2.87	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	259.92	41.08	2.99	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	273.86	39.39	4.09	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	192.11	33.60	1.72	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	218.36	29.11	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	265.88	43.65	3.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	238.31	30.77	3.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	232.50	23.46	0.71	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	211.73	33.00	3.44	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	204.50	31.67	2.68	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	214.13	24.24	2.02	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	229.65	32.97	3.70	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	140.71	12.79	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	203.09	26.44	3.17	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	229.69	38.01	4.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	170.09	29.80	1.45	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	245.29	40.63	2.30	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	228.88	39.46	6.41	1.48	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	195.71	31.99	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	261.47	37.71	0.50	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	212.69	40.11	4.06	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	175.55	20.65	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	251.17	46.76	2.23	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	238.13	37.15	1.56	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	186.71	28.37	3.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	242.34	30.10	1.04	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	241.10	39.38	3.50	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	181.15	29.07	2.24	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	239.37	39.75	3.97	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	242.61	37.41	3.09	1.54	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	159.00	28.36	1.52	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	214.84	36.53	2.88	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	223.42	38.16	3.18	1.59	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	201.73	28.56	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	220.65	29.05	1.38	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	224.57	34.58	2.28	1.14	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	219.48	29.95	0.52	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	275.12	30.23	3.63	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	230.39	34.54	1.27	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	222.30	36.25	1.07	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	258.60	35.05	2.30	1.15	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	242.72	38.57	2.57	2.06	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	234.84	26.88	3.54	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	341.06	31.78	3.40	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	256.69	43.68	2.91	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	236.48	34.45	2.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	311.07	40.50	1.67	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	261.13	41.35	3.25	0.00	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	250.22	36.80	2.68	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	314.37	44.91	3.21	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	300.24	29.90	1.62	0.40	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	235.86	30.29	1.84	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	307.63	32.01	8.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	315.14	43.31	3.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	223.17	23.77	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	327.76	38.30	2.19	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	303.80	32.96	3.56	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	269.05	29.89	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	298.40	26.52	2.65	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	263.98	41.57	6.24	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	46.27	25.30	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	71.93	14.50	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	63.44	24.25	0.52	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	52.57	14.34	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	77.17	43.89	0.16	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	137.74	48.65	0.69	0.28	0.14
Mammary Epithelial Cell, donor1	11273-116H4	105.12	87.89	0.40	0.20	0.00
Mammary Epithelial Cell, donor2	11350-117G9	114.66	72.68	0.87	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	118.48	52.38	0.75	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	170.16	33.90	0.00	0.00	0.68
Mast cell, donor1	11563-120D6	133.77	58.83	0.32	0.97	1.19
Mast cell, donor2	11565-120D8	112.33	94.50	1.49	0.59	0.59
Mast cell, donor3	11566-120D9	106.71	106.48	0.00	0.23	1.13
Mast cell, donor4	11567-120E1	109.56	93.08	0.89	0.35	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	116.77	66.09	1.00	0.89	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	130.16	37.94	1.17	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	111.40	68.95	1.38	0.34	1.03
Mast cell, expanded, donor8	11941-126A6	177.07	71.30	0.17	0.50	2.34
Melanocyte - dark, donor1	11502-119F8	178.60	41.59	0.99	0.10	0.30
Melanocyte - dark, donor2	11582-120F7	106.59	53.99	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	133.44	63.02	0.58	0.29	0.00
Melanocyte - light, donor1	11274-116H5	108.84	50.78	0.24	0.00	0.71
Melanocyte - light, donor2	11351-117H1	79.85	55.96	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	85.86	45.10	2.60	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	155.15	58.31	1.46	0.52	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	108.11	35.23	1.08	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	80.62	44.20	1.07	0.54	1.07
Meningeal Cells, donor1	11493-119E8	335.46	179.89	0.62	0.12	0.37
Meningeal Cells, donor2	11573-120E7	189.26	96.39	0.44	0.44	0.88
Meningeal Cells, donor3	11654-122E7	205.06	111.01	0.90	0.08	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	98.38	61.59	1.43	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	85.84	27.57	0.50	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	61.77	49.94	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	139.97	122.97	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	124.86	94.72	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	65.44	40.87	0.21	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	74.39	35.69	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	206.13	139.76	1.76	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	189.95	105.94	2.19	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	186.80	89.82	1.64	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	53.19	49.31	0.55	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	115.23	77.69	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	74.60	48.95	0.92	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	85.16	55.49	0.89	0.30	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	105.10	51.38	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	140.89	80.05	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	150.28	85.42	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	71.61	39.40	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	130.62	55.88	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	84.59	22.27	0.27	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	50.05	14.51	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	92.43	30.64	0.79	0.29	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	40.51	9.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	55.66	23.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	70.38	19.73	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	34.71	20.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	52.27	19.50	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	62.06	30.28	0.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	49.34	9.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	57.51	21.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	49.10	17.82	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	57.52	21.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	56.23	22.80	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	5.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	54.97	27.16	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	24.86	6.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	46.20	14.31	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	3.35	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	44.16	24.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	42.07	14.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.06	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	47.20	18.65	0.92	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	44.80	13.04	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	43.82	14.27	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	41.84	21.88	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	36.90	12.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	46.65	15.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.31	5.07	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	42.40	11.69	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	40.29	9.70	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	48.54	15.86	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	52.43	12.81	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	19.20	8.23	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	57.57	22.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	6.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	60.43	21.90	0.44	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	18.76	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.05	2.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	75.37	26.03	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	22.96	2.78	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	8.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	73.16	27.69	0.68	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	28.88	5.69	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	29.12	6.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	63.97	27.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.51	6.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.07	10.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	50.08	14.78	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	54.26	14.19	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	35.10	14.78	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	52.93	10.81	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	43.80	14.92	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	54.16	17.36	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	52.76	9.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	14.61	3.81	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	34.70	12.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	55.38	23.05	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	32.35	17.37	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	45.23	21.98	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	56.39	16.14	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	25.79	10.24	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	44.60	22.44	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	60.96	15.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.08	9.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	34.11	24.70	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	56.22	26.81	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	30.91	25.14	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	37.82	28.29	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	22.60	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	10.69	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	63.41	38.77	0.66	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	66.27	24.19	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	35.58	23.92	0.20	0.59	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	56.81	24.21	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	40.93	22.53	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	50.87	23.44	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	43.77	21.38	0.23	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	47.15	32.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	65.59	38.11	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	73.11	40.45	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	34.20	16.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	42.50	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	76.76	37.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	41.74	20.66	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	40.86	9.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	7.29	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	43.80	7.55	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	531.05	34.26	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	277.31	32.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	90.30	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	188.24	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	102.76	43.73	0.65	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	72.12	25.09	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	65.41	39.38	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	35.06	18.78	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	78.34	33.66	0.38	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	73.41	43.09	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	31.96	18.36	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	9.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	30.13	22.60	1.26	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	49.97	23.01	0.70	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	46.48	26.48	0.81	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	44.15	38.68	0.21	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	22.27	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	55.10	35.24	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	42.77	18.41	0.00	0.00	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	38.99	24.71	0.00	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.76	14.21	0.65	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	49.21	28.98	0.36	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	37.66	28.64	0.53	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	46.22	23.41	1.20	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	48.57	10.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	27.97	15.29	0.33	0.16	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	42.68	26.63	0.18	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	25.32	19.69	1.41	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	30.80	18.39	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	34.38	19.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	56.56	14.49	2.07	1.03	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	15.17	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	31.19	19.38	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	31.75	10.58	0.00	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	26.58	12.58	0.95	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	39.92	19.32	1.29	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	35.99	21.99	0.33	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	28.40	17.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	26.98	11.51	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	32.50	18.57	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	40.11	17.41	0.00	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	42.04	11.41	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.05	12.64	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	40.71	14.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	51.15	9.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	27.26	15.96	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	38.20	19.84	0.99	0.50	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	45.17	11.48	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	52.63	29.03	1.51	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	43.76	19.45	0.00	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	40.66	11.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	43.90	26.22	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	35.88	5.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.33	15.74	0.30	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.93	19.78	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	62.35	11.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	25.29	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	59.51	21.74	0.25	0.37	0.25
Myoblast, donor2	11322-117D8	92.63	41.04	1.34	0.38	0.00
Myoblast, donor3	11398-118D3	89.97	40.86	0.17	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	138.49	78.07	1.46	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	96.87	87.95	0.00	1.23	0.00
Natural Killer Cells, donor2	11311-117C6	80.82	63.63	2.11	1.81	0.00
Natural Killer Cells, donor3	11387-118C1	92.58	67.00	0.37	2.21	0.00
Neural stem cells, donor1	11275-116H6	179.29	173.12	1.09	0.00	0.36
Neural stem cells, donor2	11352-117H2	82.80	109.76	0.00	0.00	0.00
Neurons, donor1	11494-119E9	137.69	85.34	0.00	2.28	0.00
Neurons, donor2	11574-120E8	68.03	52.62	0.44	0.00	0.00
Neurons, donor3	11655-122E8	110.17	40.29	0.82	3.29	0.00
Neutrophils, donor1	11233-116C9	67.74	38.05	0.93	0.00	0.93
Neutrophils, donor2	11314-117C9	69.57	26.09	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	57.42	31.76	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	74.68	57.47	1.42	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	42.65	53.40	0.33	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	43.12	37.70	0.60	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	60.70	32.07	1.24	0.41	0.00
Olfactory epithelial cells, donor2	11934-125I8	73.82	35.61	1.59	1.01	0.14
Olfactory epithelial cells, donor3	11935-125I9	72.19	31.44	1.02	0.57	0.00
Olfactory epithelial cells, donor4	11936-126A1	66.13	30.58	0.58	0.10	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	147.45	80.04	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	64.23	33.39	0.00	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	32.01	13.72	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	25.45	27.31	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	127.82	79.93	0.00	0.00	0.78
Osteoblast, donor2	11354-117H4	193.14	109.56	2.81	1.40	0.00
Osteoblast, donor3	11426-118G4	132.94	55.27	0.71	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	76.82	53.32	0.76	0.17	0.25
Pericytes, donor1	11491-119E6	108.26	59.97	0.33	0.00	0.67
Pericytes, donor2	11571-120E5	66.78	44.82	0.68	0.23	0.23
Pericytes, donor3	11652-122E5	131.02	62.87	1.02	0.41	0.20
Perineurial Cells, donor1	11499-119F5	94.26	71.99	1.02	0.00	0.45
Perineurial Cells, donor2	11579-120F4	119.61	60.73	0.28	0.09	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	115.70	98.81	0.64	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	62.93	67.58	1.71	1.47	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	105.47	72.21	0.26	1.68	0.00
Placental Epithelial Cells, donor1	11278-116H9	204.49	77.49	1.67	0.00	1.20
Placental Epithelial Cells, donor2	11355-117H5	104.24	54.34	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	180.03	72.64	1.57	0.39	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	58.23	27.53	0.95	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	52.71	25.14	0.38	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	104.29	64.87	0.39	0.65	0.00
Preadipocyte - breast, donor2	11328-117E5	59.44	31.52	0.45	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	61.06	22.91	0.43	0.11	0.32
Preadipocyte - omental, donor2	11329-117E6	58.49	34.48	1.31	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	70.76	30.08	0.29	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	76.77	20.67	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	157.55	58.66	0.31	0.00	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	212.32	102.53	4.43	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	120.39	54.66	1.02	0.00	0.85
Preadipocyte - visceral, donor1	11280-116I2	135.90	94.82	0.75	0.47	0.28
Preadipocyte - visceral, donor2	11357-117H7	98.48	67.65	1.84	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	127.48	57.78	1.46	0.31	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	294.46	44.50	1.21	1.06	1.06
Prostate Epithelial Cells, donor2	11331-117E8	88.15	28.44	0.95	0.14	0.95
Prostate Epithelial Cells, donor3	11404-118D9	64.79	59.58	0.73	1.35	0.43
Prostate Stromal Cells, donor1	11254-116F3	122.10	55.01	1.14	0.11	0.46
Prostate Stromal Cells, donor2	11332-117E9	135.55	65.44	1.08	0.72	0.54
Prostate Stromal Cells, donor3	11405-118E1	61.84	38.37	0.94	0.10	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	187.24	158.40	1.09	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	101.96	69.31	1.04	0.21	0.21
Renal Epithelial Cells, donor1	11517-119H5	352.53	215.57	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	235.45	101.72	2.13	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	105.55	77.49	0.42	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	220.60	70.13	6.13	0.68	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	209.83	59.03	1.48	0.27	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	190.93	60.39	1.78	0.00	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	216.27	63.88	1.33	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	249.80	109.38	0.66	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	180.57	86.52	1.25	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	190.30	67.41	1.94	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	235.41	147.36	0.81	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	147.59	68.74	0.42	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	226.02	105.29	1.74	0.39	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	149.61	82.71	0.78	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	201.53	80.73	1.42	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	226.41	93.65	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	114.41	65.74	0.25	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	103.57	46.51	0.40	0.40	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	76.83	34.84	0.89	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	194.28	103.47	1.10	8.81	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	96.29	40.60	1.16	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	158.37	68.13	0.78	0.26	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	182.13	71.30	1.89	0.70	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	168.98	78.41	1.23	0.33	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	207.40	81.74	1.36	0.37	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	204.42	82.05	2.45	0.93	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	179.36	72.81	2.31	1.62	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	152.38	68.73	0.82	0.96	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	182.89	62.78	0.91	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	142.64	66.66	0.72	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	178.17	84.21	1.00	1.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	187.48	72.33	2.15	0.54	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	178.79	67.04	1.77	0.89	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	147.21	64.62	0.19	1.15	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	167.79	65.96	1.02	0.65	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	164.98	92.45	1.13	0.94	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	146.51	60.65	0.80	0.80	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	196.92	69.99	1.75	0.39	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	182.75	73.33	2.10	2.86	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	164.03	68.67	0.64	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	182.76	78.21	4.20	0.84	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	153.47	73.66	1.03	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	149.51	66.55	0.91	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	197.56	81.06	1.96	1.23	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	195.03	69.71	2.55	1.07	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	192.71	96.71	0.71	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	198.02	87.30	2.18	0.99	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	171.64	76.00	2.34	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	178.95	81.70	1.04	0.62	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	159.49	69.46	3.54	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	169.82	73.53	1.04	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	181.96	81.42	0.94	0.81	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	158.20	65.39	1.02	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	166.57	60.54	1.35	2.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	189.48	82.53	0.52	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	156.78	56.79	1.10	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	150.54	63.70	1.64	0.66	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	143.50	69.88	1.02	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	185.83	72.06	1.33	0.59	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	122.35	60.77	0.27	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	137.16	72.31	0.41	0.83	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	156.20	73.57	0.95	0.95	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	154.38	72.35	0.81	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	161.51	84.47	1.04	0.85	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	157.21	61.84	1.75	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	109.40	45.03	0.00	1.21	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	173.79	97.42	1.71	0.98	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	143.81	84.86	0.29	0.73	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	96.74	48.07	2.43	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	154.32	97.95	0.90	0.60	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	160.82	61.52	0.90	1.13	3.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	147.97	74.59	0.30	2.10	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	162.59	72.85	1.18	0.35	6.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	158.80	60.83	0.21	0.21	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	110.58	57.69	0.00	1.80	0.00
Schwann Cells, donor1	11498-119F4	196.53	107.76	0.75	0.19	1.13
Schwann Cells, donor2	11578-120F3	142.90	108.88	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	104.72	78.65	1.97	0.00	0.00
Sebocyte, donor1	11220-116B5	273.34	113.39	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	143.38	59.74	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	118.93	66.37	0.62	0.41	0.41
Sertoli Cells, donor1	11255-116F4	117.62	48.04	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	48.01	19.77	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	98.89	101.61	0.88	0.44	0.79
Skeletal Muscle Cells, donor2	11358-117H8	25.30	23.85	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	216.53	125.41	3.34	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	135.73	71.95	1.57	0.16	0.31
Skeletal Muscle Cells, donor5	11455-119A6	124.86	71.80	1.34	0.74	0.00
Skeletal Muscle Cells, donor6	11459-119B1	163.44	82.80	1.39	0.77	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	109.88	85.18	0.63	0.25	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	103.59	67.21	2.14	1.43	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	176.79	84.23	1.19	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	101.10	64.03	0.34	0.17	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	94.09	86.13	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	60.13	35.78	0.55	0.28	0.00
Skin - palm, donor1	10286-104F7	26.86	40.29	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	85.20	21.19	1.73	0.00	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	261.73	112.87	2.45	12.27	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	127.10	28.43	2.08	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	73.95	49.21	0.56	0.00	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	75.25	29.82	0.98	0.28	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	212.50	93.88	0.21	4.44	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	70.53	43.10	0.52	0.67	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	47.21	40.42	0.62	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	63.36	60.92	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	75.83	38.80	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	188.73	106.52	0.22	0.00	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	103.96	54.34	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	61.81	39.40	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	61.05	40.03	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	80.65	53.23	0.00	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	79.13	42.56	0.89	0.22	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	47.37	21.13	0.26	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	64.47	35.81	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	88.60	41.35	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	67.05	25.91	0.57	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	147.06	123.63	0.33	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	50.23	44.14	1.22	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	96.73	66.93	0.00	0.00	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	355.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	82.97	48.16	1.91	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	66.36	45.13	0.59	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	96.21	46.92	0.43	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	104.43	51.32	0.63	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	135.19	63.73	0.00	0.00	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	78.69	36.65	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	77.70	39.15	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	224.64	159.09	0.68	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	79.31	60.70	0.47	0.39	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	62.40	49.41	0.20	0.10	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	108.09	48.47	0.91	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	89.36	47.70	0.60	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	261.75	129.28	1.59	1.06	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	100.67	58.72	0.93	0.40	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	87.15	44.58	0.88	0.75	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	36.78	31.45	1.01	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	101.32	61.36	1.06	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	51.76	35.26	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	581.50	372.16	0.00	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	97.20	66.51	1.40	0.00	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	79.77	40.39	3.03	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	65.81	36.04	0.31	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	55.16	48.97	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	151.04	99.72	0.33	0.08	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	38.31	43.91	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	82.90	58.72	0.29	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	118.55	65.01	1.02	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	105.49	55.28	0.75	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	127.87	93.07	0.42	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	80.19	55.38	0.42	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	72.86	116.66	2.38	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	86.85	52.85	0.49	0.00	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	106.72	33.36	0.88	0.00	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	67.88	64.95	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	40.23	27.99	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	46.81	30.68	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	65.46	39.80	0.74	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	42.76	30.90	1.08	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	42.02	31.51	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	139.43	67.75	1.18	1.58	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	45.97	32.76	0.76	1.52	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	24.36	37.54	0.40	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	31.77	21.74	0.42	2.09	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	42.63	29.79	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	131.29	40.57	0.67	0.67	0.17
Synoviocyte, donor2	11368-117I9	61.69	28.50	0.50	0.00	0.00
Synoviocyte, donor3	11440-118H9	49.60	20.55	0.89	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	320.17	245.13	1.79	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	103.07	101.08	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	152.59	112.53	0.93	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	123.01	67.31	0.29	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	127.18	49.09	0.39	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	154.05	60.70	1.15	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	113.80	47.73	0.25	0.12	0.86
Urethra, donor2	10319-105A4	41.36	16.19	0.00	5.40	0.00
Urothelial Cells, donor1	11520-119H8	138.68	96.97	1.33	0.27	0.27
Urothelial Cells, donor2	11600-120H7	89.73	55.68	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	109.10	62.34	0.69	0.23	0.00
Urothelial cells, donor0	11216-116B1	93.62	81.80	0.89	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	106.77	85.42	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	100.07	60.04	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	82.14	40.39	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	75.75	60.60	1.38	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	69.72	73.21	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	98.92	84.34	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	115.64	78.01	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	88.55	51.12	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	198.61	66.99	1.97	0.99	0.37
Wilms' tumor cell line:HFWT	10597-108E3	101.20	27.28	0.88	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	222.34	115.36	0.84	1.12	0.00
achilles tendon, donor2	10292-104G4	16.53	24.80	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	266.68	124.93	1.78	1.78	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	345.01	182.72	0.93	1.63	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	296.18	184.12	0.95	1.07	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	426.95	105.04	0.54	2.99	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	297.11	131.27	2.53	3.94	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	160.30	74.86	0.42	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	240.09	84.66	0.27	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	276.28	107.08	2.20	2.20	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	209.08	83.71	1.23	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	293.17	106.78	1.55	1.55	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	355.86	111.14	2.39	0.37	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	202.83	93.61	3.90	39.01	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	269.80	77.62	2.79	0.46	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	490.62	148.87	2.59	0.78	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	330.53	83.00	1.75	2.34	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	151.05	39.50	0.46	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	227.83	86.77	1.65	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	124.31	23.94	1.23	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	354.59	84.06	1.71	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	373.66	93.72	0.30	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	413.53	95.56	0.48	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	263.95	91.99	1.78	0.89	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	315.54	56.37	0.33	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	139.37	48.31	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	219.59	73.83	0.75	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	384.67	79.38	0.87	2.18	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	84.35	26.24	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	166.73	75.12	0.00	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	70.58	50.57	1.09	0.00	1.86
adipose, donor1	10184-103D4	126.66	106.14	3.52	2.35	5.86
adipose, donor2	10185-103D5	38.52	79.89	1.22	1.62	2.03
adipose, donor3	10186-103D6	83.59	69.43	0.54	2.72	1.63
adipose, donor4	10187-103D7	149.95	126.55	3.47	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	145.35	70.07	0.79	0.47	0.63
adrenal gland, adult, pool1	10081-102A9	40.01	14.55	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	84.18	103.66	0.27	0.27	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	263.69	100.76	2.14	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	82.31	32.92	0.70	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	80.47	40.91	0.68	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	74.24	35.94	1.18	0.29	0.00
amygdala - adult, donor10196	10167-103B5	11.86	15.42	0.00	3.56	0.00
amygdala, adult, donor10252	10151-102I7	35.08	24.53	0.20	0.81	0.00
amygdala, newborn, donor10223	10360-105E9	33.89	14.20	0.00	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	88.88	57.04	0.00	0.25	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	222.61	181.57	1.54	1.99	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	177.71	67.14	0.00	3.34	0.00
aorta, adult, pool1	10052-101G7	56.68	47.66	0.59	0.00	0.20
appendix, adult	10189-103D9	117.21	51.23	0.39	1.55	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	110.40	63.63	0.34	0.00	0.34
artery, adult	10190-103E1	33.97	16.30	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	123.28	86.63	1.01	0.72	0.29
b cell line:RPMI1788	10427-106D4	124.17	132.49	0.74	0.89	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	45.50	27.19	0.55	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	214.64	61.72	1.19	0.50	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	145.28	32.81	0.67	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	162.18	57.04	0.56	3.36	0.00
bladder, adult, pool1	10011-101C2	50.08	49.32	0.76	0.00	0.22
blood, adult, pool1	10053-101G8	50.94	53.15	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	50.52	34.25	0.86	0.00	0.00
bone marrow, adult	10192-103E3	105.95	41.16	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	27.68	14.35	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	18.15	17.59	0.00	0.00	0.11
brain, fetal, pool1	10085-102B4	40.07	34.73	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	117.61	21.14	1.65	3.30	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	167.89	69.03	0.62	0.50	0.00
breast, adult, donor1	10080-102A8	66.29	32.20	0.63	0.00	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	172.52	74.83	1.14	0.38	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	126.78	69.57	0.93	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	87.48	96.92	0.69	1.61	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	140.65	25.42	0.48	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	190.89	119.89	0.94	2.82	0.00
carcinoid cell line:NCI-H727	10735-110B6	168.99	58.19	0.44	0.55	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	164.79	125.17	1.58	2.22	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	135.22	113.66	3.46	1.33	0.27
caudate nucleus - adult, donor10196	10177-103C6	28.78	26.48	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	28.78	21.08	0.17	0.67	0.00
caudate nucleus, adult, donor10258	10379-105H1	11.46	15.28	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	42.12	21.24	0.00	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	37.87	67.01	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	43.56	38.22	0.21	2.99	0.00
cerebellum, adult, pool1	10083-102B2	15.18	21.39	0.00	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	48.99	31.55	0.00	3.32	0.00
cerebral meninges, adult	10188-103D8	18.66	8.57	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	18.27	13.89	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	120.35	174.70	1.01	0.14	0.43
cervical cancer cell line:ME-180	10553-107I4	196.21	78.55	0.00	0.66	0.00
cervix, adult, pool1	10013-101C4	89.14	63.73	0.63	0.00	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	129.03	60.33	0.70	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	24.82	11.76	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	306.22	111.85	1.62	1.12	2.61
choriocarcinoma cell line:SCH	10785-110H2	246.42	29.32	0.74	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	181.92	40.56	0.24	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	97.73	30.77	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	105.99	43.25	0.70	0.00	0.60
chorionic membrane cells, donor3	12240-129G8	119.24	32.97	0.00	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	313.04	51.50	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	243.77	70.31	0.77	0.96	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	246.24	41.60	1.27	0.84	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	196.45	132.25	0.77	1.54	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	223.50	136.66	1.45	1.69	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	247.18	119.11	2.65	2.24	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	281.20	157.83	1.77	2.65	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	569.99	148.30	1.56	2.09	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	112.69	88.00	1.60	1.14	0.46
clear cell carcinoma cell line:TEN	10636-108I6	261.65	126.83	1.74	4.34	0.52
colon carcinoma cell line:CACO-2	10513-107D9	290.85	58.57	0.55	0.73	0.37
colon carcinoma cell line:COLO-320	10420-106C6	175.22	234.89	1.90	0.00	0.00
colon, adult, donor1	10082-102B1	105.91	54.74	0.00	2.38	1.19
colon, adult, pool1	10014-101C5	86.72	45.71	0.24	0.00	0.47
colon, fetal, donor1	10070-101I7	62.42	27.81	0.00	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	197.09	96.25	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	246.46	48.44	0.42	2.12	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	288.58	65.50	1.36	0.91	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	319.81	70.65	0.56	0.85	0.56
corpus callosum, adult, pool1	10042-101F6	47.10	45.44	0.00	0.11	0.00
cruciate ligament, donor2	10295-104G7	37.28	42.14	0.00	2.43	0.81
diaphragm, fetal, donor1	10069-101I6	31.30	20.06	0.80	0.00	0.00
diencephalon, adult	10193-103E4	14.64	15.12	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	228.69	144.88	4.82	1.38	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	107.19	63.08	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	145.64	63.55	0.24	0.96	0.24
ductus deferens, adult	10196-103E7	80.73	38.87	0.00	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	79.21	47.53	1.44	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	91.96	69.89	3.68	0.74	0.74
dura mater, adult, donor1	10041-101F5	124.38	108.77	0.33	0.25	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	313.79	261.60	1.33	0.89	4.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	277.85	200.75	1.00	1.15	1.29
embryonic pancreas cell line:1B2C6	10604-108F1	54.88	30.21	0.62	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	77.80	49.34	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	88.30	35.51	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	68.30	26.27	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	127.37	63.35	0.34	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	144.81	115.63	1.27	4.53	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	165.80	25.09	1.77	1.45	0.32
epidermoid carcinoma cell line:A431	10426-106D3	186.52	67.36	0.22	1.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	219.31	119.99	1.10	0.66	0.22
epididymis, adult	10197-103E8	81.21	36.00	0.00	0.42	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	87.46	54.29	0.18	1.24	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	139.60	31.85	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	278.61	102.22	3.54	2.36	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	292.21	110.62	3.05	1.87	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	287.58	89.96	4.15	2.91	0.22
esophagus, adult, pool1	10015-101C6	79.74	50.43	0.42	0.00	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	252.73	81.15	1.63	0.63	0.13
eye - muscle inferior rectus, donor1	10272-104E2	36.22	28.97	0.00	7.24	0.00
eye - muscle lateral, donor2	10298-104H1	18.94	14.73	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	19.35	5.95	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	25.22	22.93	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	51.01	23.32	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	69.91	37.12	0.76	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	145.92	86.17	0.90	0.77	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	172.37	82.38	0.95	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	18.67	20.55	0.00	0.09	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	214.38	57.65	0.90	1.80	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	74.89	88.05	0.27	0.18	0.09
gall bladder, adult	10198-103E9	92.71	39.35	1.21	0.48	1.21
gamma delta positive T cells, donor1	11937-126A2	105.22	114.89	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	95.24	95.99	0.75	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	156.09	28.73	0.84	0.42	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	167.50	74.47	0.97	1.35	0.00
gastric cancer cell line:AZ521	10549-107H9	231.34	149.69	0.82	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	150.10	98.84	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	129.08	49.12	1.60	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	134.82	147.56	1.26	0.46	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	96.15	107.49	0.42	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	133.19	26.19	0.25	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	131.83	60.06	0.84	0.42	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	117.69	56.74	0.28	0.70	0.14
glioblastoma cell line:T98G	10485-107A8	127.15	110.04	1.32	0.55	0.44
glioma cell line:GI-1	10413-106B8	115.69	85.23	0.29	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	21.14	21.14	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	59.56	36.86	0.24	2.20	0.00
globus pallidus, adult, donor10258	10367-105F7	19.17	23.28	1.37	2.74	1.37
globus pallidus, newborn, donor10223	10364-105F4	56.49	25.58	0.00	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	291.21	112.57	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	43.71	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	125.44	36.59	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	52.48	32.32	1.92	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	249.30	123.50	1.84	2.75	0.46
hIPS +CCl2, biol_rep2	14384-156C1	274.81	148.15	3.66	1.37	0.46
hIPS +CCl2, biol_rep3	14385-156C2	285.33	140.41	1.93	2.58	0.64
hIPS, biol_rep1	14380-156B6	117.86	176.79	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	205.07	119.34	0.69	1.37	0.69
hIPS, biol_rep3	14382-156B8	49.66	23.17	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	149.71	75.00	0.57	3.74	0.29
heart - mitral valve, adult	10205-103F7	51.72	20.93	0.60	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	37.65	19.35	0.00	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	106.58	31.64	0.83	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	90.40	39.38	1.43	2.86	0.00
heart, adult, diseased, donor1	10051-101G6	30.66	22.99	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	27.60	13.57	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	77.22	42.41	0.31	0.10	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	41.65	28.38	0.31	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	98.70	23.78	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	336.35	73.70	2.10	1.77	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	369.95	82.29	3.28	1.94	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	374.00	85.09	2.83	0.81	0.10
hepatoma cell line:Li-7	10484-107A7	158.48	96.09	0.56	0.67	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	184.22	92.96	1.11	0.50	0.10
hippocampus - adult, donor10196	10169-103B7	9.46	22.71	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	45.51	25.10	1.02	1.02	0.00
hippocampus, adult, donor10258	10374-105G5	12.95	19.92	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	25.03	15.86	0.00	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	380.85	118.41	4.27	3.05	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	266.65	109.96	3.34	1.18	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	283.86	108.41	2.29	1.27	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	124.61	153.37	1.13	2.82	5.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	157.77	156.48	5.68	1.81	7.49
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	178.42	187.53	2.28	3.42	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	99.85	96.34	1.46	2.63	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	84.66	112.45	1.29	2.59	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	91.34	84.25	0.83	1.25	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	119.11	102.77	0.71	0.95	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	162.00	127.61	3.21	1.77	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	108.40	99.65	0.67	0.00	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	289.34	97.80	3.13	0.63	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	263.82	99.24	4.42	1.47	3.93
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	342.12	96.88	2.62	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	151.01	174.11	2.29	1.15	6.68
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	123.41	199.29	3.92	1.74	5.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	117.44	125.94	0.50	2.50	9.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	57.46	112.85	0.57	0.94	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	59.11	122.32	1.82	2.73	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	55.44	98.04	0.31	3.76	2.51
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	111.21	78.71	1.96	2.61	3.43
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	114.67	80.13	3.19	1.16	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	98.35	72.94	1.20	3.29	3.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	236.66	94.40	2.40	1.66	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	273.02	110.41	3.14	0.86	3.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	360.13	109.02	2.86	3.27	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	170.76	151.75	2.46	0.35	8.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	132.08	133.98	1.90	1.58	9.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	165.84	131.94	1.51	2.42	6.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	90.50	99.80	1.55	3.10	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	82.36	88.33	0.00	1.99	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	84.40	80.04	0.26	0.26	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	161.83	98.68	2.30	0.26	3.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	120.40	94.65	2.27	1.51	5.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	123.67	76.62	1.68	1.01	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	271.21	117.86	4.11	1.21	2.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	238.87	88.24	1.78	2.23	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	246.83	97.56	2.93	3.41	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	141.20	178.79	2.75	0.00	8.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	289.54	143.14	0.00	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	206.18	185.00	1.99	2.32	7.94
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	102.89	137.37	3.28	0.00	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	87.21	95.90	1.09	0.72	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	61.57	91.81	1.42	0.71	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	102.63	95.47	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	136.24	127.98	0.54	0.27	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	92.94	77.86	1.62	2.42	1.89
immature langerhans cells, donor1	11904-125F5	85.48	67.80	0.24	0.97	0.00
immature langerhans cells, donor2	11905-125F6	102.19	49.11	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	20.06	23.19	0.19	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	102.75	30.24	1.30	0.65	0.00
kidney, adult, pool1	10017-101C8	111.84	46.86	0.70	0.10	0.60
kidney, fetal, pool1	10045-101F9	212.21	87.78	0.71	0.21	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	115.60	87.20	0.43	0.43	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	79.21	41.47	0.69	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	122.58	58.72	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	19.61	16.89	0.00	0.54	0.54
left ventricle, adult, donor1	10078-102A6	25.79	11.12	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	150.21	47.33	0.00	1.64	0.00
leiomyoma cell line:10964C	10569-108B2	41.31	21.91	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	47.28	15.22	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	49.29	29.38	1.70	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	77.37	55.41	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	211.91	81.22	0.59	1.30	0.47
liposarcoma cell line:KMLS-1	10782-110G8	53.42	35.46	0.47	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	143.53	57.14	0.61	0.61	0.12
liver, adult, pool1	10018-101C9	121.87	61.10	0.81	0.00	1.30
liver, fetal, pool1	10086-102B5	56.44	39.51	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	16.62	12.54	0.00	0.58	0.15
locus coeruleus, adult, donor10252	10165-103B3	41.15	24.73	0.18	1.11	0.00
locus coeruleus, adult, donor10258	10375-105G6	21.44	13.26	0.56	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	104.31	28.60	0.00	1.68	0.84
lung adenocarcinoma cell line:A549	10499-107C4	102.55	24.63	0.42	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	101.34	60.67	0.00	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	74.61	65.51	0.53	0.53	0.26
lung, adult, pool1	10019-101D1	79.15	53.75	0.71	0.00	0.47
lung, fetal, donor1	10068-101I5	190.37	117.87	0.00	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	63.23	25.20	0.92	0.46	0.46
lymph node, adult, donor1	10077-102A5	97.51	53.96	0.47	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	100.82	113.97	0.66	1.75	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	199.52	115.61	0.45	0.15	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	95.99	61.16	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	39.52	22.20	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	47.52	31.34	0.00	0.00	0.42
mature adipocyte, donor3	12233-129G1	40.06	36.03	0.00	0.00	0.47
mature adipocyte, donor4	12234-129G2	28.69	29.74	0.00	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	100.31	78.63	0.48	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	18.05	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	33.65	21.15	0.74	0.92	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	7.94	8.58	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	31.56	12.79	0.00	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	17.38	19.91	1.86	1.01	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	37.99	25.89	0.00	2.12	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	5.78	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.48	11.13	0.00	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	25.96	22.71	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	50.62	31.27	0.15	1.24	0.00
medulla oblongata, adult, pool1	10038-101F2	38.94	36.41	0.08	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	60.41	25.34	0.69	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	198.16	212.56	0.66	1.77	0.00
medulloblastoma cell line:ONS-76	10759-110E3	166.78	65.91	0.86	0.73	0.12
melanoma cell line:COLO 679	10514-107E1	156.83	59.65	0.43	0.57	0.86
melanoma cell line:G-361	10465-106H6	96.64	94.74	0.27	1.36	0.81
meningioma cell line:HKBMM	10691-109F7	70.19	51.20	1.63	0.72	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	960.46	48.46	8.81	7.05	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	388.58	129.09	2.85	2.85	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	121.37	56.77	0.61	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	66.53	38.17	0.36	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	87.79	53.01	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	48.04	33.57	0.14	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.99	28.31	0.58	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	63.86	47.89	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	31.41	28.83	0.17	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	77.64	38.88	1.04	0.35	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	87.54	45.49	0.80	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	101.69	43.21	0.27	0.27	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	103.57	43.11	0.57	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	34.91	45.78	0.66	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	107.51	46.63	0.69	0.28	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	79.59	51.32	0.70	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	46.14	31.65	0.41	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	61.47	41.34	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	51.52	37.97	0.21	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	69.77	22.57	0.68	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	130.06	57.90	0.42	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	72.93	40.95	0.60	0.00	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	92.87	45.34	0.53	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	46.02	40.87	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	80.12	39.78	0.86	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	149.46	59.78	2.11	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	62.11	31.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	63.43	38.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	60.47	43.45	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	67.16	38.51	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	60.49	35.30	0.47	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	65.66	37.57	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	50.30	39.30	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	67.65	33.83	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	74.99	41.24	0.29	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	63.36	35.03	0.67	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	64.89	37.74	0.24	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	68.93	25.67	1.47	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	53.71	33.90	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	50.35	36.03	0.41	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	58.42	35.65	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	32.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	30.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	62.36	38.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	59.65	33.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	63.97	34.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	67.87	30.26	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	47.42	34.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	44.07	31.48	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	35.76	30.80	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	45.07	29.65	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	53.61	38.99	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	48.77	36.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	33.11	27.94	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	36.54	36.54	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	23.95	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	24.11	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	32.60	24.86	0.41	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.93	19.86	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	34.19	18.86	0.00	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	37.09	20.88	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	40.10	40.10	0.00	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	41.39	26.02	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	53.93	28.25	2.57	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	49.56	22.03	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	35.63	28.20	0.99	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	48.22	26.92	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	34.35	34.98	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.00	32.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	54.51	41.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	29.14	50.68	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.88	41.27	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	49.71	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	24.71	38.71	1.65	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	31.55	22.22	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	29.53	17.85	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	47.88	32.60	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	47.20	10.83	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	81.03	105.84	0.71	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	187.89	52.36	0.46	1.62	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	106.84	29.92	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	128.95	46.75	0.51	0.82	0.21
mesothelioma cell line:Mero-25	10850-111F4	197.68	67.41	1.13	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	201.20	80.43	0.49	0.73	0.49
mesothelioma cell line:Mero-48a	10852-111F6	123.12	65.54	0.66	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	218.92	70.96	0.79	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	136.52	48.68	1.36	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	178.71	37.41	1.26	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	170.40	56.73	0.83	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	175.75	67.75	0.99	0.33	0.33
mesothelioma cell line:NCI-H226	10846-111E9	206.51	40.54	1.45	0.36	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	107.28	80.12	0.51	0.51	0.00
mesothelioma cell line:NCI-H28	10845-111E8	105.86	66.16	1.02	0.51	0.00
mesothelioma cell line:No36	10857-111G2	100.80	64.26	1.63	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	100.25	50.67	2.17	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	106.33	57.58	0.38	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	73.64	51.78	0.37	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	66.41	45.05	0.36	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	123.08	72.48	1.96	0.98	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	77.57	42.39	1.27	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	130.61	56.44	0.00	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	149.76	55.76	0.57	0.38	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	416.52	93.32	1.11	0.74	0.00
myeloma cell line:PCM6	10474-106I6	82.62	78.67	0.79	0.99	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	100.95	14.71	0.00	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	111.60	110.23	0.20	1.37	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	57.50	63.29	0.22	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	53.76	58.32	0.29	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	71.76	124.75	0.00	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	83.05	110.20	0.23	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	188.02	216.27	0.75	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	120.21	115.57	2.11	1.05	0.21
neuroblastoma cell line:NH-12	10555-107I6	204.99	189.15	0.75	2.05	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	105.33	75.67	1.42	2.37	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	134.94	71.43	1.43	3.64	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	179.12	125.59	0.81	0.60	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	130.33	61.03	0.64	1.91	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	83.58	25.29	0.53	0.53	0.00
neutrophil PMN, donor1	12133-128D9	29.75	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	28.41	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	292.58	254.36	2.20	2.37	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	57.64	58.44	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	75.66	37.51	1.28	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	88.03	40.73	1.31	0.53	0.53
nucleus accumbens, adult, pool1	10037-101F1	23.72	22.22	0.00	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	14.42	22.66	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	54.75	31.67	0.27	0.81	0.00
occipital cortex, newborn, donor10223	10355-105E4	28.39	15.29	0.00	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	14.69	10.76	0.00	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	21.46	24.46	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	18.21	19.87	0.00	0.08	0.00
olfactory region, adult	10195-103E6	15.67	17.96	0.19	0.76	0.19
optic nerve, donor1	10277-104E7	18.01	18.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	178.72	70.62	0.80	0.11	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	135.33	93.97	0.69	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	135.97	50.97	2.71	0.17	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	216.46	85.01	0.81	1.27	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	82.02	39.10	0.00	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	125.20	88.76	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	166.68	110.48	0.42	0.85	0.00
ovary, adult, pool1	10020-101D2	99.67	58.09	0.35	0.00	1.22
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	70.40	39.78	0.37	0.92	0.00
pancreas, adult, donor1	10049-101G4	92.18	54.56	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	285.41	58.98	1.40	1.68	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	162.18	70.02	2.21	1.02	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	121.21	40.24	0.17	0.66	0.33
paracentral gyrus, adult, pool1	10035-101E8	18.30	16.93	0.18	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	15.41	36.70	0.00	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	7.52	28.21	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	32.21	21.09	0.00	1.14	0.00
parietal lobe, adult, pool1	10034-101E7	22.03	20.53	0.09	0.26	0.00
parietal lobe, fetal, donor1	10072-101I9	28.13	28.13	0.00	2.91	0.00
parietal lobe, newborn, donor10223	10356-105E5	32.90	14.21	0.00	1.12	0.00
parotid gland, adult	10199-103F1	156.63	50.57	1.85	0.00	0.62
penis, adult	10200-103F2	51.56	35.99	0.54	1.61	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	163.07	142.06	1.67	0.56	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	143.95	53.32	0.87	0.58	0.44
pineal gland - adult, donor10196	10179-103C8	17.42	18.71	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	38.49	20.14	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	25.71	14.42	0.63	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	81.96	81.96	0.00	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	119.35	94.33	0.52	2.61	2.61
pituitary gland, adult, donor10258	10378-105G9	95.34	62.99	0.00	0.85	1.70
placenta, adult, pool1	10021-101D3	144.16	63.10	0.32	0.11	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	127.13	125.67	1.19	0.79	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	67.39	33.62	0.00	0.31	0.31
pons, adult, pool1	10033-101E6	17.73	18.25	0.00	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	16.21	20.40	0.09	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	167.31	69.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	121.18	49.57	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	164.30	58.68	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	190.96	93.95	1.02	1.75	0.29
prostate cancer cell line:PC-3	10439-106E7	160.99	86.39	0.73	0.91	0.18
prostate, adult, pool1	10022-101D4	77.81	47.07	0.36	0.09	0.91
putamen, adult, donor10196	10176-103C5	18.18	22.90	0.00	1.18	0.00
putamen, adult, donor10252	10152-102I8	25.49	13.73	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	85.24	65.57	2.19	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	20.05	15.22	0.00	0.48	0.00
putamen, newborn, donor10223	10365-105F5	58.47	24.74	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	131.79	33.75	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	63.99	44.51	4.17	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	70.81	51.09	0.00	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	22.78	53.43	0.00	0.41	0.41
retina, adult, pool1	10030-101E3	96.52	59.34	0.60	0.30	0.20
retinoblastoma cell line:Y79	10475-106I7	141.85	156.14	1.04	1.56	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	320.16	28.89	1.35	3.32	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	136.94	143.69	0.84	1.12	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	62.90	21.98	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	63.45	44.19	0.49	0.16	0.49
salivary acinar cells, donor2	11772-123I8	66.92	52.05	1.10	0.14	0.41
salivary acinar cells, donor3	11773-123I9	28.47	20.52	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	156.71	70.92	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	131.53	102.44	0.42	0.42	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	100.86	93.22	0.82	0.35	0.00
seminal vesicle, adult	10201-103F3	68.25	41.27	0.53	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	143.33	36.20	2.19	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	84.05	47.06	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	176.62	92.33	2.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	185.09	36.40	0.94	0.67	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	135.40	63.33	0.55	0.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	169.67	67.22	0.65	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	5.67	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	33.22	19.67	0.36	0.12	0.24
skeletal muscle, fetal, donor1	10066-101I3	41.21	35.18	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	27.14	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	102.89	46.08	1.26	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	131.41	92.39	0.67	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	176.51	154.14	1.89	5.36	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	84.81	113.53	0.96	1.16	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	190.71	207.35	0.82	0.33	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	70.29	142.83	0.48	1.29	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	122.25	92.18	1.31	0.44	0.00
small intestine, adult, pool1	10024-101D6	123.62	53.15	0.48	0.36	0.84
small intestine, fetal, donor1	10064-101I1	125.55	46.93	2.70	1.23	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	115.40	44.62	1.03	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	44.71	30.76	1.55	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	52.80	57.89	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	24.32	16.52	0.00	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	39.03	27.99	0.39	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	29.75	24.90	0.00	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	48.79	32.93	0.00	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	72.56	30.31	0.46	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	84.53	41.07	0.90	0.45	0.00
spleen, adult, pool1	10025-101D7	101.65	61.57	0.44	0.22	0.66
spleen, fetal, pool1	10044-101F8	176.39	82.79	1.35	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	143.57	104.03	0.72	0.31	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	119.43	45.19	0.38	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	185.91	56.61	2.80	1.40	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	126.27	50.82	0.39	1.95	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	262.82	140.81	1.01	1.24	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	202.06	93.62	1.69	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	230.15	98.15	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	28.84	27.77	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	107.67	47.28	0.57	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	56.91	29.91	0.42	1.04	0.00
substantia nigra, adult, donor10258	10371-105G2	24.31	18.10	0.00	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	36.74	19.08	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	277.87	160.49	2.75	1.38	0.23
temporal lobe, adult, pool1	10031-101E4	22.80	24.75	0.08	0.17	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	32.05	21.37	0.71	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	34.72	29.01	0.44	0.88	0.00
tenocyte, donor1	11763-123H8	94.96	64.93	1.75	0.70	0.00
tenocyte, donor2	11765-123I1	61.04	29.76	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	69.69	41.51	1.11	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	459.40	164.69	2.72	0.85	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	156.00	96.34	1.23	0.31	0.62
teratocarcinoma cell line:PA-1	10807-111A6	238.82	143.82	0.93	0.77	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	407.76	112.22	2.41	1.27	1.90
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	256.02	149.38	1.13	1.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	273.75	88.99	1.64	0.87	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	271.31	75.89	7.82	1.63	0.33
testis, adult, pool1	10026-101D8	78.81	68.83	0.97	0.11	4.08
testis, adult, pool2	10096-102C6	104.65	85.71	1.35	0.00	0.45
thalamus - adult, donor10196	10168-103B6	15.46	25.39	1.10	3.31	0.00
thalamus, adult, donor10252	10154-103A1	53.92	28.76	0.00	1.56	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	30.79	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	13.67	9.72	0.49	0.82	0.16
thalamus, newborn, donor10223	10366-105F6	28.77	7.48	0.58	0.00	0.00
throat, adult	10209-103G2	82.14	36.95	0.25	0.00	0.25
throat, fetal, donor1	10061-101H7	66.73	41.74	0.91	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	250.80	102.35	1.19	2.98	0.40
thymus, adult, pool1	10027-101D9	228.85	120.99	0.99	0.00	1.69
thymus, fetal, pool1	10043-101F7	204.69	114.09	0.83	0.31	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	114.08	74.72	0.66	0.40	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	149.61	93.73	1.40	0.56	0.42
thyroid, adult, pool1	10028-101E1	134.00	58.88	0.65	0.00	1.21
thyroid, fetal, donor1	10060-101H6	78.57	38.49	0.53	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	15.40	0.00	0.00	0.00
tongue, adult	10203-103F5	87.68	41.17	1.86	0.00	1.16
tongue, fetal, donor1	10059-101H5	53.99	35.07	0.79	0.00	0.39
tonsil, adult, pool1	10047-101G2	167.29	96.07	0.60	0.00	0.00
trachea, adult, pool1	10029-101E2	112.23	59.47	0.33	0.08	0.98
trachea, fetal, donor1	10058-101H4	79.25	38.08	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	113.72	44.99	0.71	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	258.66	93.41	0.91	0.51	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	166.56	157.47	0.78	2.82	1.10
tridermal teratoma cell line:HGRT	10694-109G1	47.56	15.22	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	98.28	39.11	0.76	0.42	0.17
umbilical cord, fetal, donor1	10057-101H3	77.20	33.38	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	108.18	82.07	0.34	0.00	0.17
uterus, fetal, donor1	10055-101H1	103.92	52.22	1.02	0.00	0.00
vagina, adult	10204-103F6	62.04	27.79	0.65	0.00	0.00
vein, adult	10191-103E2	79.57	49.54	0.44	0.00	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	59.82	75.57	0.27	0.27	0.00

Property "Nearest transcripts" (as page type) with input value "LF330724:-136 MA566301:-136 ENST00000621737.4:-181 ENST00000587136.1:266 NR_039900.2:348 LG052883:348 LY497759:348 LY498822:348 LY499259:348 LY500574:348 LZ238806:348 MS869493:348 MS880574:348 MS996825:348 MA822766:348 LY616570:348 MB407900:348 MC002669:348 LY497940:349 LY497941:349 LY498841:349 LY498842:349 LY499547:349 LY499548:349 LY500762:349 LY500763:349 LZ239094:349 LZ239095:349 MS869681:349 MS869682:349 MS880862:349 MS880863:349 MS997006:349 MS997007:349 FR773039:349 LF137547:349 LF160757:349 LF162512:349 LF953264:349 LG005609:349 LG053305:349 LG240544:349 LP951884:349 LQ072167:349 LQ724689:349 LV470629:349 LY497582:349 LY498806:349 LY498981:349 LY500388:349 LZ238546:349 MA406097:349 MA645668:349 MA733552:349 MS869307:349 MS880296:349 MS996648:349 MA802721:349 MA823108:349 MA822429:349 MP129319:349 MP162242:349 MP168085:349 LY616858:349 LY616859:349 LY616310:349 MB407933:349 MB407857:349 MB481512:349 MC002644:349 FR773038:385 LF160811:385 LQ072166:385 MA405828:385 MA645667:385 MA733551:385 MA802720:385" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.